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Background
The HIV-1 envelope (Env) transmembrane protein, gp41,
is typically considered a type I membrane protein with an
extracellular N-terminus, a single membrane spanning
domain, and a C-terminus forming a ~150 residue intrac-
ytoplasmic tail. However, published studies have indi-
cated an alternative or dynamic topology for portions of
the C-terminal tail (CTT) that results in exposure of spe-
cific CTT segments on the membrane surface.
Methods
To distinguish between these alternative CTT models, we
evaluated the accessibility of a reference CTT sequence,
the ''Kennedy epitope'' (KE), in viral and cellular mem-
branes to map CTT topology relative to the lipid bilayer.
Specifically, KE accessibility in cell-associated Env was
defined by reactivity of native or VSV-G epitope-tagged KE
to specific monoclonal antibodies (MAbs), measured by
FACS of intact cells. In parallel, KE exposure in virion-
associated Env was characterized by MAb binding to intact
virions as measured in immunoprecipitation or surface
plasmon resonance (SPR/Biacore) assays.
Results
Results of FACS analyses of live cell-associated Env indi-
cated significant reactivity of the KE with MAbs to native
or VSV-G epitope-tagged KE. Additionally, no antibody
reactivity was observed in cells expressing Env with the
VSV-G epitope substituted into the LLP2 segment. In con-
trast to cellular Env, KE in the context of virions failed to
react with MAbs directed to the native KE sequence, as
measured both by immunoprecipitation and Biacore
assays. However, MAbs specific for the gp41 MPER seg-
ment bound virions in both assays.
Conclusion
Taken together, the results of these accessibility assays
indicate that the KE sequences of gp41 are accessible to
antibody binding in cell surface-expressed Env, but not
accessible to antibody binding in virion-associated Env.
These observations suggest that the CTT may assume dis-
tinct topologies (reflected in KE exposure) that depend on
the membrane environment (viral/cellular) and that parts
of the CTT may be (transiently) exposed on the mem-
brane surface.
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